文献速递肝病

法国全国HIV队列中HIV感染者糖尿病风险与肝硬化相关而非慢性HCV合并感染

Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.
PubMed 文献 · Aliment Pharmacol Ther · 2018-06-14

在法国多中心Dat'AIDS队列中纳入28699例HIV感染者,其中4004例合并慢性HCV感染,采用Cox模型分析糖尿病发生。多因素分析显示肝硬化(HR 2.26,95%CI 1.14-1.18;P<0.0001)是糖尿病的预测因素,而慢性HCV、HBV感染及基于干扰素的HCV治疗与糖尿病无关。

要点

  • 肝硬化是HIV感染者发生糖尿病的预测因素(HR 2.26,95%CI 1.14-1.18;P<0.0001)。
  • 慢性HCV感染、慢性HBV感染及基于干扰素的HCV治疗与糖尿病发生无关。
  • 在HCV感染患者亚组分析中,持续病毒学应答与糖尿病无关。

核心结论

  • 在HIV人群中,肝硬化与糖尿病发生增加相关,而慢性HCV感染或HCV感染持续时间与糖尿病无关。

研究设计与样本

  • 法国多中心Dat'AIDS队列中所有HIV感染者纳入分析,共28699例,其中4004例合并慢性HCV感染。
  • 采用Cox生存分析模型研究糖尿病发生时间。

主要发现

  • 糖尿病的发生率比为每1000人年2.74。
  • 多因素分析中,年龄增加、体重指数>25、AIDS状态、最低CD4细胞计数≤200/mm3、可检测的HIV病毒载量及肝硬化(HR 2.26,95%CI 1.14-1.18;P<0.0001)是糖尿病的预测因素。
  • 较长的联合抗逆转录病毒治疗(cART)持续时间与较低的糖尿病风险相关。
  • 慢性HCV感染、慢性HBV感染及基于干扰素的HCV治疗与糖尿病无关。
  • 在HCV感染患者亚组分析中,持续病毒学应答与糖尿病无关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Both human immunodeficiency virus (HIV) and hepatitis C virus (HCV) infections have been reportedly associated with a higher risk of diabetes mellitus (DM) but results are conflicting. AIMS: To determine whether there is an association between chronic HCV and the incidence of DM, and to study the role of factors such as cirrhosis, IFN-based HCV therapy, sustained virologic response (SVR) and chronic HBV infection among patients living with HIV (PLHIV) followed in a large French multicentre cohort in the combination antiretroviral therapy (cART) era. METHODS: All PLHIV followed up in the Dat'AIDS cohort were eligible. Cox models for survival analysis were used to study the time to occurrence of DM. RESULTS: Among 28 699 PLHIV, 4004 patients had chronic HCV infection. The mean duration of HCV follow-up was 12.5 ± 8.1 years. The rate ratio of DM was 2.74 per 1000 person-years. By multivariate analysis, increasing age, body mass index>25, AIDS status, nadir CD4 cell count ≤200/mm3 , detectable HIV viral load and cirrhosis (HR 2.26 95% CI 1.14-1.18; P < 0.0001) were predictors of DM, whereas longer cART duration was associated with a lower risk of DM. Chronic HCV and HBV infection and IFN-based HCV therapy were not associated with DM. In a subanalysis among HCV-infected patients, SVR was not related to DM. CONCLUSIONS: Our study shows that in the HIV population, cirrhosis is associated with an increased occurrence of DM, but not chronic HCV infection or duration of HCV infection.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Provoost A, Dramé M, Cotte L, et al. Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort. Aliment Pharmacol Ther. 2018. PMID: 29901821. doi:10.1111/apt.14812

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。